Susquehanna Fundamental Investments, LLC Biogen Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $9.52 Million - $13.1 Million	-48,876 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $9.47 Million - $11.9 Million	48,876 New	48,876 $10.3 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $6.01 Million - $7.73 Million	-26,862 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $7.6 Million - $9.91 Million	26,862 New	26,862 $7.6 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.